Literature DB >> 33755900

Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage.

Siriwal Suwanpitak1, Nutchanawan Promnakhon1,2, Ratchapong Netsrithong1,2, Methichit Wattanapanitch3.   

Abstract

One of the major obstacles for adoptive cell transfer (ACT) of T cells is the loss of effector function and proliferative ability of isolated antigen-specific T cells after prolonged ex vivo expansion. To overcome this issue, induced pluripotent stem cells (iPSCs), which have unlimited proliferation and differentiation potential, can be used to generate a large number of antigen-specific T cells. Here, we describe an efficient differentiation protocol for the generation of cytotoxic CD8+ T cells from human T cell-derived iPSCs (T-iPSCs). The protocol consists of three main steps including differentiation of T-iPSCs toward hematoendothelial progenitors (HEPs), co-culture of HEPs with OP9-DL1 cells, and stimulation of T cell receptor (TCR) signaling to obtain CD8 single-positive (SP) T cells. This culture system is simple and efficient; therefore, will offer a powerful tool for studying T cell development and applications in adoptive immunotherapy.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  Adoptive cell transfer; CD8 T cells; Hematoendothelial progenitors; Induced pluripotent stem cells; OP9-DL1 cells

Mesh:

Year:  2022        PMID: 33755900     DOI: 10.1007/7651_2021_355

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Phenotypic and functional characterization of c-kit expression during intrathymic T cell development.

Authors:  D I Godfrey; A Zlotnik; T Suda
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

  1 in total
  2 in total

Review 1.  Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.

Authors:  Jennifer H Hammel; Jonathan M Zatorski; Sophie R Cook; Rebecca R Pompano; Jennifer M Munson
Journal:  Adv Drug Deliv Rev       Date:  2022-01-11       Impact factor: 15.470

Review 2.  Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells.

Authors:  Ratchapong Netsrithong; Methichit Wattanapanitch
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.